Related Experiment Videos
Transformation capacity of human blood lymphocytes in relation to their specific gravity; another heterogeneity of
European Journal of Immunology
|June 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Guidelines for the optimal use of muromonab CD3 in transplantation.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta.
Journal of neuroimmunology·2002
Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales.
Clinical and diagnostic laboratory immunology·2001
Phenotypical and functional analysis of T cells in periodontitis.
Journal of periodontal research·2001
Parasite-Derived IL-33 Inhibitors Prevent Bleomycin-Induced Lung Fibrosis.
European journal of immunology·2026
Immunomodulatory Receptor ILT3/LILRB4 Protects Human Leukemic B Cells From Ferroptosis In Vitro.
European journal of immunology·2026
The Role of Sodium in Th17/Treg Immune Dysregulation and Autoimmunity.
European journal of immunology·2026
PGE2 Enhances Human ILC3 Function but Constrains ILC2-to-ILC3 Plasticity.
European journal of immunology·2026
Synovial Fluid Immune Cell Landscape in Juvenile Idiopathic Arthritis.
European journal of immunology·2026
Mast Cells Regulate Epithelial Barrier Integrity and Myeloid Immune Responses in Experimental Colitis.
European journal of immunology·2026
Eculizumab in rapidly progressive glomerulonephritis: a case-series report.
Frontiers in immunology·2026
Flurbiprofen for Inflammatory Bowel Disease: A Review of Colon-Targeted Formulations.
Recent advances in drug delivery and formulation·2026
Heart-specific T cell responses: from antigens to disease mechanisms.
Nature reviews. Cardiology·2026
Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.
Critical reviews in oncology/hematology·2026